human gbm cell line a172 (Korean Cell Line Bank)
86
Structured Review
Korean Cell Line Bank
human gbm cell line a172
Human Gbm Cell Line A172, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a172+cell+line/a172+cell+gbm+human+line/pm41915273-31-0-8
Average 86 stars, based on 1 article reviews
Human Gbm Cell Line A172, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/a172+cell+line/a172+cell+gbm+human+line/pm41915273-31-0-8
Average 86 stars, based on 1 article reviews
human gbm cell line a172 - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Cell Culture:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Irradiation:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Knockdown:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Transfection:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Western Blot:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Transwell Migration Assay:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Invasion Assay:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Clonogenic Assay:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Staining:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Expressing:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Knock-Out:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Derivative Assay:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Incubation:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Radioactivity:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Marker:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article Cell Viability Assay:Article Title: FK506: an immunosuppressive agent preserving HIF-1 activity. Article Snippet: During transplantation, donor organs or cells are subjected to hypoxia.. Hypoxia-inducible factor-1 (HIF-1) is essential for cellular adaptation to hypoxia.. Immunosuppressive agents should be used for preventing graft rejection, but of these, rapamycin and cyclosporine A have been reported to inhibit HIF-1. Article Title: Efficient generation of recombinant anti-HER2 scFv with high yield and purity using a simple method. Article Snippet: A172, SK-BR-3, MDA-MB-231, and Article Title: DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma. Article Snippet: Article |
![Autophagosome accumulation in GBM cells, expressed as mean fluorescence intensity (MFI), for control untreated cells and cells treated with [HuArgI (Co)-PEG5000] at 24, 48, 72, 96, and 120 hours post-treatment. Stars indicate a significant increase in autophagosome accumulation compared to untreated cells (A). Autophagosome accumulation in A172 and U251 cell lines at 72 hours post-treatment in untreated cells and cells treated with CQ, [HuArgI (Co)-PEG5000] and a combination of both. MFI is on the X-axis (FL1-H) and forward scatter is on the Y-axis (B). Immunohistochemistry staining of autophagosomes in A172 cells untreated and treated with CQ, [HuArgI (Co)-PEG5000], or a combination of both, at 24, 48, and 72 hours, post-treatment (C).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6220/pmc13166220/pmc13166220__ICNS_A_2666026_F0002_C.jpg)
![Western blot of Atg13 and phosphor-Atg13 on protein extracts of A172 and U251 untreated and treated with [HuArgI (Co)-PEG5000] for up to 96 hours (Atg13) (A). Histogram of the ratio of p-Atg13 over Atg13 showing a significant decrease in the phosphorylation of Atg13 at 72- and 96-hours post-treatment. Stars indicate statistical significance (A). ULK phosphorylation levels expressed as mean fluorescence intensity (MFI), for untreated cells and cells treated with [HuArgI (Co)-PEG5000] at 24, 48, 72, 96, and 120 hours post-treatment. Double stars indicate significantly lower ULK phosphorylation in treated compared to untreated cells (B). ULK phosphorylation is also shown in A172 and U251 cell lines at 24- and 48-hours post-treatment in isotype controls, untreated cells and cells treated with [HuArgI (Co)-PEG5000]. MFI is represented on the X-axis (FL1-H) and forward scatter is represented on the Y-axis. Last panel on the right is a histogram representing the overlayed phospho-ULK MFI of the isotype control (red), untreated cells (black) and cells treated with [HuArgI (Co)-PEG5000] (blue) (B). Cytotoxicity of [HuArgI (Co)-PEG5000] alone and in combination with chloroquine (CQ) (50 µM) to A172 and U251 cells at 48, 72, 96, and 120 hours (C).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6220/pmc13166220/pmc13166220__ICNS_A_2666026_F0003a_C.jpg)
![Intracellular ROS accumulation in GBM cells following treatment with [HuArgI (Co)|-PEG5000], expressed as both percent positive cells (left panel) and mean fluorescence intensity (MFI) (right panel). Stars indicate a significant increase in ROS accumulation. The bottom histograms show ROS accumulation in treated cells (red) compared to controls (black) in A172 and U251 cells. (A) Autophagosome accumulation in GBM cells, expressed as MFI, for control untreated cells and cells treated with [HuArgI (Co)-PEG5000] alone or a combination of [HuArgI (Co)-PEG5000] and N-acetylcysteine (NAC) at 24, 48, 72, 96, and 120 hours post-treatment (B). Autophagosome formation in A172 and U251 cell lines. Control untreated cells (left panel) and cells treated with [HuArgI (Co)-PEG5000] (10 −7 M) (middle panel) or treated with [HuArgI (Co)-PEG5000] and NAC (0.82 g/L) (right panel) at 24, 48, 72, 96, and 120-hours post-treatment. In the histogram (right panel), control cells are in black, cells treated with [HuArgI (Co)-PEG5000] are in red and cells treated with the combination with NAC are in blue (C). Cytotoxicity of A172 and U251 cells treated with [HuArgI (Co)-PEG5000] alone or in combination with N-acetylcysteine (NAC) (0.82 g/L) (D).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6220/pmc13166220/pmc13166220__ICNS_A_2666026_F0004a_C.jpg)
